Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Express Scripts
Healthtrust
Deloitte
McKinsey
Covington
Queensland Health
UBS

Generated: July 15, 2018

DrugPatentWatch Database Preview

Vigabatrin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Pharmacology for vigabatrin
Medical Subject Heading (MeSH) Categories for vigabatrin
Synonyms for vigabatrin
.gamma.-vinyl GABA
.gamma.-Vinyl-.gamma.-aminobutyric acid
.gamma.-Vinyl-GABA
( inverted exclamation markA)-4-aminohex-5-enoic acid
( inverted question mark)-gamma-Vinyl GABA
(?)-4-AMINOHEX-5-ENOIC ACID
(?)-gamma-Vinyl GABA
(+-)-gamma-Vinyl GABA
(+/-)-?-Vinyl GABA
(+/-)-4-Amino-5-hexenoic acid
(+/-)-4-Aminohexenoic acid
(+/-)-gamma-Vinyl GABA
(+/-)-gamma-Vinyl-GABA
(+/-)-Vigabatrin
(1)-4-Aminohex-5-enoic acid
(A+/-)-gamma-Vinyl GABA
(inverted question mark)-gamma-Vinyl GABA
(R,S)-4-Amino-5-hexenoic acid
(y)-gamma-Vinyl GABA
4-Amino-5-hexenoic acid
4-Amino-hex-5-enoic acid
4-aminohex-5-enoic acid
4-Aminohexenoic acid
5-Hexenoic acid, 4-amino-
60643-86-9
68506-86-5
AB00053309
AB00053309_04
AB0010729
AC1L1KUZ
Acid, gamma-Vinyl-gamma-Aminobutyric
ACN-036276
AK117754
AKOS015854596
AM010202
AN-39442
AOB6800
AS-11778
Aventis Brand of Vigabatrin
BDBM50118886
Biomol-NT_000247
BPBio1_000465
BPBio1_000925
BRD-A07893380-001-01-6
BSPBio_000421
BSPBio_003469
C07500
CAS-60643-86-9
CCG-205350
CHEBI:63638
CHEMBL89598
CPP 109
CPP-109
CPP109
CS-0791
CTK7D4255
D00535
D0R3QY
DB01080
DivK1c_006760
DR000126
DSSTox_CID_21153
DSSTox_GSID_41153
DSSTox_RID_79637
DTXSID4041153
EINECS 270-929-6
EU-0101277
FT-0700968
gamma Vinyl GABA
gamma Vinyl gamma Aminobutyric Acid
gamma-Vinyl GABA
gamma-Vinyl GABA; 4-Amino-5-hexenoic acid
gamma-Vinyl-GABA
gamma-Vinyl-gamma-Aminobutyric Acid
GTPL4821
GVG
Hexenoic acid, 4-amino
HMS1569F03
HMS2094M21
HMS2096F03
HMS3263P16
Hoechst Brand of Vigabatrin
HY-15399
KB-240224
KB-81443
KBio1_001704
KBio2_000848
KBio2_003416
KBio2_005984
KBio3_002973
KBioSS_000848
Lopac0_001277
LP01277
LS-75569
M071754
MDL 71,754
MDL 71754
MDL-71754
MFCD00274577
MolPort-003-666-796
NCGC00016087-03
NCGC00016087-04
NCGC00016087-05
NCGC00016087-06
NCGC00016087-07
NCGC00016087-08
NCGC00016087-09
NCGC00016087-11
NCGC00024802-02
NCGC00024802-03
NCGC00024802-04
NCGC00024802-05
NCGC00024802-06
NCGC00261962-01
PJDFLNIOAUIZSL-UHFFFAOYSA-N
Prestwick_837
Prestwick0_000501
Prestwick1_000501
Prestwick2_000501
Prestwick3_000501
Q-201924
RMI 71754
RMI-71754
RMI-71890
Sabril
Sabril (TN)
Sabrilex
Sabrilex (TN)
SBI-0051243.P003
SC-20397
SCHEMBL26714
SPBio_002342
SpecPlus_000664
Spectrum_000368
SPECTRUM1502036
Spectrum3_001825
SR-01000075653
SR-01000075653-6
Tox21_110301
Tox21_501277
V 8261
V8261_SIGMA
Vigabatrin (JAN/USAN/INN)
Vigabatrin [USAN:BAN:INN]
Vigabatrin [USAN:INN:BAN]
Vigabatrin Aventis Brand
vigabatrin HCl
Vigabatrin Hoechst Brand
Vigabatrin Yamanouchi Brand
Vigabatrin, European Pharmacopoeia (EP) Reference Standard
Vigabatrin, United States Pharmacopeia (USP) Reference Standard
Vigabatrina
Vigabatrina [Spanish]
Vigabatrine
Vigabatrine [French]
Vigabatrinum
Vigabatrinum [Latin]
Vinyl .gamma.-aminobutyric Acid
VINYL GAMMA-AMINOBUTYRIC ACID
W-5102
Yamanouchi Brand of Vigabatrin
Z2235791448

US Patents and Regulatory Information for vigabatrin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa VIGABATRIN vigabatrin FOR SOLUTION;ORAL 209824-001 Apr 23, 2018 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms VIGABATRIN vigabatrin FOR SOLUTION;ORAL 210155-001 Mar 13, 2018 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aucta Pharms VIGADRONE vigabatrin FOR SOLUTION;ORAL 210196-001 Jun 21, 2018 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm Inc VIGABATRIN vigabatrin FOR SOLUTION;ORAL 208218-001 Apr 27, 2017 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
Queensland Health
Chubb
US Army
Farmers Insurance
Teva
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.